Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$230.71 - $256.74 $193,334 - $215,148
-838 Closed
0 $0
Q1 2022

Apr 27, 2022

BUY
$219.27 - $242.57 $183,748 - $203,273
838 New
838 $203,000
Q3 2021

Nov 01, 2021

SELL
$212.27 - $248.7 $195,288 - $228,804
-920 Closed
0 $0
Q2 2021

Jul 26, 2021

BUY
$233.58 - $259.14 $467 - $518
2 Added 0.22%
920 $224,000
Q1 2021

Apr 27, 2021

BUY
$221.91 - $258.6 $203,713 - $237,394
918 New
918 $228,000
Q4 2020

Feb 08, 2021

SELL
$216.38 - $257.67 $200,151 - $238,344
-925 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $5,631 - $6,262
24 Added 2.66%
925 $235,000
Q2 2020

Aug 06, 2020

BUY
$197.81 - $242.74 $178,226 - $218,708
901 New
901 $213,000
Q1 2019

May 16, 2019

SELL
$180.87 - $203.88 $25,321 - $28,543
-140 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$178.4 - $208.25 $24,976 - $29,155
140 New
140 $27,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wealthpoint, LLC Portfolio

Follow Wealthpoint, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthpoint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthpoint, LLC with notifications on news.